Retatrutide (10mg) vial
In Stock & Lab Verified

Retatrutide

10mg Lyophilised Powder

$139.99AUD per vial

Concentration

10mg

CAS Number

2381089-83-2

Volume Savings

1
Express shipping available Australia-wide
Independently laboratory tested with CoA available
Availability

Ready to purchase now

In stock now and ready for checkout.

Same-day dispatch cutoff

Order within the current dispatch window

Melbourne cut-off time updates live every second.

Time Remaining

07:48:25

Purity as reported on CoA: 99.216%

Frequently Bought Together

BPC-157 (10mg)

Support

BPC-157 (10mg)

$89.99

GLOW Peptide Blend (50mg)

Support

GLOW Peptide Blend (50mg)

$168.99

Product Information

Retatrutide 10mg Research Peptide – Premium-Grade Compound for Laboratory Use

Retatrutide (10mg) from Aus Peptide Supply is a high-purity research peptide developed specifically for controlled laboratory and in-vitro research applications. Manufactured under strict quality standards, this triple GLP-1/GIP/Glucagon receptor agonist is supplied for scientific investigation and analytical purposes only.

Product Highlights

  • High Purity Standard – Produced using advanced synthesis and purification processes, batch-verified at 99.216% purity as reported on the CoA.
  • Research-Grade Quality Control – Subjected to rigorous third-party analytical testing for identity and purity verification via HPLC and mass spectrometry.
  • Secure Packaging – Delivered in sterile, sealed vials to maintain compound integrity during transport and storage.
  • Reliable Domestic Sourcing – Dispatched from within Australia in compliance with established laboratory handling and quality assurance protocols.

Intended Use

Retatrutide (10mg) is intended exclusively for laboratory research and scientific study. It is not intended for human or veterinary use, therapeutic application, or consumption. Researchers are responsible for ensuring proper handling, storage, and application in accordance with applicable regulations and institutional guidelines.

Storage & Handling

  • Store in a cool, dry environment away from direct light. Lyophilised vials should be kept at -20°C.
  • Reconstitute using appropriate laboratory-grade solvents (such as bacteriostatic water) where applicable.
  • Follow standard laboratory safety procedures when handling peptide compounds.

For researchers seeking a dependable source of high-quality peptides for experimental investigation, Retatrutide (10mg) offers consistency, precision, and reliable formulation suitable for professional research environments. Fast domestic shipping to all Australian states and territories, with batch-specific CoA information available in our CoA Library.

⚠ For in-vitro research and laboratory use only. Not for human consumption.

Frequently Asked Questions

What is Retatrutide?
Retatrutide is a synthetic peptide that acts as a triple agonist at the GLP-1, GIP, and glucagon receptors simultaneously. This tri-receptor activity profile is what separates it from earlier compounds like semaglutide (GLP-1 only) and tirzepatide (GLP-1/GIP), and is the basis for the significant fat loss results observed in Phase 2 clinical trials.
What is Retatrutide also known as?
In the research community, Retatrutide is commonly referred to as Reta peptide or simply Reta. It is also sometimes searched for as Reda peptide or Retatrude — both common misspellings. The shorthand r3ta peptide (using a numeral 3) also appears frequently in online research communities. One particularly common autocorrect error is 'ratatouille peptide' — if that's what brought you here, you're in the right place.
Can I buy Retatrutide pens at Chemist Warehouse in Australia?
No. Retatrutide is not available as a pre-filled pen, injectable device, or commercial pharmaceutical product in Australia — and is not stocked at retail pharmacies like Chemist Warehouse. It is an investigational research compound that has not been approved for human use by the TGA. Aus Peptide Supply supplies Retatrutide exclusively as a 10mg lyophilised powder for in-vitro laboratory research purposes. We do not offer 100mg bulk quantities or pen formats — if you have seen these advertised elsewhere, exercise caution regarding the source and purity verification.
Can Australian compounding pharmacies supply Retatrutide now, and when will it be released commercially?
Retatrutide is still an investigational compound, not an approved commercial medicine currently available to the public in Australia. Aus Peptide Supply does not supply Retatrutide as a compounded prescription product or pharmacy medicine — we supply research-grade lyophilised powder for lawful in-vitro laboratory research only. Lilly states that Retatrutide is not yet available for public use, remains in Phase 3 clinical trials, and that public launch depends on the completion of those trials plus regulatory approval, with additional Phase 3 results anticipated in 2026. For researchers searching terms like 'retatrutide compounding pharmacy australia' or 'retatrutide australia release date 2026', the practical distinction is that approved pharmacy release has not happened yet, while research-grade Retatrutide is already available now for legitimate in-vitro research.
What does the research show about Retatrutide?
Phase 2 clinical trials observed mean body weight reductions of up to 24% over 48 weeks — significantly outperforming semaglutide and tirzepatide in head-to-head comparisons. Subjects also showed dramatic reductions in waist circumference, visceral fat, and improvements across key cardiometabolic markers. The appetite suppression observed was described as profound, with energy intake reductions sustained throughout the trial period.
How does Retatrutide work?
Retatrutide targets three receptor pathways at once: GLP-1 receptors reduce appetite and slow gastric emptying; GIP receptors enhance insulin sensitivity and may amplify fat loss; and glucagon receptors increase energy expenditure by stimulating the liver to burn more fuel. The combined effect on all three pathways is what produced the 24% mean weight reduction observed in Phase 2 trials.
How do you reconstitute Retatrutide?
Retatrutide is supplied as a lyophilized powder and should be reconstituted with bacteriostatic water (BAC water) immediately before use. Inject the BAC water slowly into the vial, directing the stream down the inside wall. Gently swirl to dissolve — do not shake. Once reconstituted, store at 2–8°C and use within 28 days. For a full step-by-step walkthrough, see our complete peptide reconstitution guide.
How should Retatrutide be stored?
Store lyophilized Retatrutide vials at -20°C, away from light and moisture. After reconstitution, refrigerate at 2–8°C and use within 28 days. Do not freeze reconstituted solution.
Where to buy Retatrutide in Australia?
Retatrutide (10mg) is available through Aus Peptide Supply, with fast domestic shipping to all Australian states and territories. Every vial is dispatched from within Australia — no customs delays, no international freight uncertainty. Each batch undergoes third-party analysis and the Certificate of Analysis is available to view in our CoA library.
What is the cost of Retatrutide in Australia?
Retatrutide (10mg) is priced at $139.99 per vial at Aus Peptide Supply. All orders ship domestically within Australia, and batch CoAs are available in our CoA library.
How to get Retatrutide online?
Ordering is straightforward — add Retatrutide (10mg) to your cart on the Aus Peptide Supply website and complete checkout through our secure payment system. All orders are fulfilled domestically and shipped with tracking to any address across Australia. Each batch is third-party tested at ≥99% purity, with the Certificate of Analysis available to view in our CoA library.
Is Retatrutide used for weight loss research?
Yes — Reta weight loss research is by far the most active area of investigation for this compound. Retatrutide's tri-receptor mechanism (GLP-1, GIP, and glucagon) produces a combined effect on appetite suppression, energy expenditure, and fat oxidation that no single or dual agonist has matched in clinical trials to date. Phase 2 data showing a mean 24% body weight reduction over 48 weeks has made it the benchmark compound for researchers studying next-generation obesity and metabolic disease interventions. Researchers working in this space consistently reach for Retatrutide as the most advanced GLP-1 class compound currently available for study.

Purchase Other Quantities

Retatrutide is also available in other vial sizes. Compare the current formats below and jump straight to the quantity that fits your protocol.

Retatrutide (10mg)

PEP-007-10MG

Current

$139.99

Available to purchase now

Viewing this quantity →

Retatrutide (20mg)

PEP-024-20MG

$229.99

Currently unavailable

View this quantity →

Retatrutide (30mg)

PEP-019-30MG

$329.99

Currently unavailable

View this quantity →

Retatrutide (60mg)

PEP-025-60MG

$549.99

Currently unavailable

View this quantity →